SEPSIS 3 Critera for Risk Stratification in Emergency Patients
Launched by SOCIETE FRANÇAISE DE MEDECINE D'URGENCE · Apr 8, 2016
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult that present to the emergency department
- • Diagnosis of infection by the treating emergency physician
- Exclusion Criteria:
- • Refuse to participate
- • pregnancy
- • prisoner
- • Low acuity infection (localised, not requiring general treatment, without any abnormal vital parameters)
About Societe Française De Medecine D'urgence
Société Française de Médecine d'Urgence (SFMU) is a leading organization dedicated to advancing the field of emergency medicine in France. Comprising healthcare professionals, researchers, and educators, SFMU focuses on improving patient care through innovative clinical trials, evidence-based research, and the dissemination of best practices in emergency medical services. The society actively collaborates with various stakeholders, including hospitals, academic institutions, and governmental bodies, to enhance emergency care standards and foster professional development within the field. Through its commitment to research and education, SFMU aims to address critical challenges in emergency medicine and contribute to the overall improvement of healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, , Switzerland
Angers, , France
Bruxelles, , Belgium
Bobigny, , France
Paris, , France
Lyon, , France
Nice, , France
Toulouse, , France
Paris, , France
Paris, , France
Paris, , France
Beaumont S Oise, , France
Bry Sur Marne, , France
Dijon, , France
Grenoble, , France
Longjumeau, , France
Monaco, , France
Nancy, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Paris, , France
Strasbourg, , France
Tours, , France
Vienne, , France
Barcelona, , Spain
Patients applied
Trial Officials
Yonathan Freund, MD, PhD
Principal Investigator
SFMU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials